By means of in vitro and in vivo studies, Kinugasa et al. demonstrated that CAFs expressing the stemness marker CD44 sustain the stemness features of melanoma CSCs via a direct interaction and promote cancer cell drug resistance [313]. This evidence concerns the gene CD44 and melanoma.